December 17, 2021 – OssDsign AB (Sweden) received an Innovative Technology contract from Vizient Inc. (Irving, TX) for its patient-specific cranial implant OssDsign Cranial PSI. The contract received the award based on the recommendation of OssDsign Cranial PSI by hospital experts who serve on one of Vizient’s member-led councils.
OssDsign Cranial PSI is a patient-specific cranial implant designed for the reconstruction of cranial defects, an area of treatment where post-operative infections have been shown to be a common form of complication. The implant is made from 3D printed medical-grade titanium covered by a calcium phosphate composition. While the titanium skeleton reinforces the implant and resists physical and mechanical stress, the unique calcium phosphate composition provides healing and regenerative properties, allowing regrowth of the patient’s own bone. Over time, the osteoconductive ceramic component degrades and is replaced with bone, leaving the patient with a well-integrated implant, potentially lasting a lifetime.
Innovative Technology contracts are recommended after review and interaction with products submitted through Vizient’s Innovative Technology Program. Vizient member-led councils identify technologies that have the potential to enhance clinical care, patient safety, healthcare worker safety or improve business operations of healthcare organizations.